跳至主要内容
临床试验/JPRN-UMIN000009201
JPRN-UMIN000009201已完成未知

Efficacy and Safety of Tolvaptan in Heart Failure Patients with Renal Impairment and Volume Overload Despite the Standard Treatment with Conventional Diuretics - K-STAR

Kanagawa Aquaresis Investigators0 个研究点目标入组 100 人开始时间: 2012年10月27日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • subjects who already administered injected HF medications (including diueretics, inotropes and vasodilators), and who already use mechanical support (mechanical ventilator such as NIPPV, IABP, PCPS, hemodialysis and hemodiafiltration) / history of allergy against tolvaptan or similar compounds / anuria / subjects who cannot feel thirsty or have difficulty to drink / hyponatremia / subjects who are pregnant or possibly pregnant /subjects who already have tolvaptan at the time of randomization / acute coronary syndrome or those who are planned percutaneous coronary intervention / malignancy / patients who are judged to be inappropriate to this study

研究者

发起方
Kanagawa Aquaresis Investigators

相似试验